GHM

Business Context and Reporting Period

Company: Graham Corporation (NYSE: GHM)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Second quarter of fiscal 2025 ended September 30, 2024.
Business Overview: A global leader in mission-critical fluid, power, heat transfer, and vacuum technologies serving defense, space, energy, and process industries. The company operates through its Batavia, NY headquarters and subsidiaries including Barber-Nichols (Colorado), P3 Technologies (Florida, acquired Nov 2023), and international entities in China and India.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 19% ($8.5M) in Q2 and 12% ($10.9M) YTD compared to the prior year. Growth was driven by a 23% increase in Defense sales, the acquisition of P3 Technologies ($0.9M incremental revenue in Q2), and increased sales in Refining and Chemical/Petrochemical markets.
• Margin Expansion: Gross margin improved by 790 basis points in Q2 to 23.9%, attributed to higher sales volume leveraging fixed overhead, improved project mix, better execution, and a $0.4M benefit from a BlueForge Alliance grant.
• Expense Increases: SG&A expenses rose $2.8M in Q2 due to the BN Performance Bonus ($1.1M), ERP implementation costs, P3 integration, and increased R&D and personnel costs.
• Profitability: Net income surged 698% in Q2 and 105% YTD, significantly outpacing revenue growth due to margin expansion and a lower effective tax rate (24% in Q2 vs. 37% prior year).
• Backlog: Increased to $407.0M, a 30% increase year-over-year, driven by new Defense and Space contracts, including the MK19 Air Turbine Pump for the U.S. Navy Columbia-class submarine.

Guidance, Outlook, and Risks

Updated Fiscal 2025 Guidance

• Net Sales: $200.0M - $210.0M (Unchanged)
• Gross Profit Margin: 23% - 24% (Raised from 22% - 23%)
• SG&A Expenses: 17% - 18% of sales (Raised from 16.5% - 17.5%)
• Effective Tax Rate: 20% - 22% (Unchanged)
• Adjusted EBITDA: $18.0M - $21.0M (Raised from $16.5M - $19.5M)
• Capital Expenditures: $13.0M - $18.0M (Raised from $10.0M - $15.0M) to fund a land purchase in Colorado and a cryogenic testing facility in Florida.

Risks and Contingencies

• Legal Proceedings: The company faces asbestos-related personal injury lawsuits; management believes resolution will not be material but acknowledges inherent uncertainties.
• Internal Investigation: An investigation into Graham India Private Limited (GIPL) identified employee misconduct totaling $150k over four years. Employees were terminated, and the company has reported findings to the DOJ and SEC. Management does not expect a material impact on consolidated results.
• Market Risks: Exposure to foreign currency fluctuations (18% of sales international), supply chain inflation, and geopolitical tensions affecting raw material costs.

Investor Verification Checklist

• Defense Concentration: Verify the sustainability of the 80% backlog concentration in the Defense sector and reliance on U.S. Navy programs.
• Grant Dependency: Confirm the timing and conditions of the $2.1M BlueForge Alliance grant impacting gross profit.
• Acquisition Integration: Monitor the integration progress and financial performance of P3 Technologies, LLC, including the contingent earn-out liability ($1.4M remaining).
• Capital Allocation: Assess the ROI on increased capital expenditures ($13M-$18M) for the new Florida testing facility and Colorado expansion.
• Regulatory Status: Track the outcome of the GIPL investigation and any potential fines or penalties from the DOJ or SEC.